Top European VC and CRO fund Young Metabolic Disease Biotech
Eternygen has received €8M in a Series A round led by Epidarex Capital that will be…
Keep up to date with the latest advances in medical biotechnology and discover how biotech is transforming and improving the way we treat disease.
Eternygen has received €8M in a Series A round led by Epidarex Capital that will be…
Immatics and Amgen have inked a deal to develop bispecific drug candidates for cancer that…
Innate Pharma has received a €14M milestone payment from BMS as their combination therapy targeting two…
Servier has signed a deal that could give it access to up to eight bispecific…
There's a growing appetite to refine and standardize CRISPR protocols, as its application expands into different…
Scientists from the UK have developed a new spider silk biomaterial that can be used…
Shire has sold its RNA therapy program to a smaller biotech that wants to accelerate…
Enterome is entering a clinical trial that will evaluate a novel therapy that targets the microbiome…
Neurokinins are under investigation for a range of conditions from women's health to pain. NeRRe…
AiCuris is developing a new antibiotic that might bring hope for patients in which all…
Tiziana Life Sciences is acquiring candidates to gain leverage in the profitable NASH market, where…
Researchers have discovered a new mechanism by which antibiotic-resistant bacteria can protect non-resistant pathogens. What…